In Conversation

“ The CEO and one of the founders of Lexel explains how the company adapts its medical devices to the specifications required by their international customers. ”
“ Carlos Chiale, National Administrator of ANMAT, discusses the agency’s latest strategy implementation and its pioneering work in the area of fighting drug falsification. ”
“ MMA’s president shares the reasons why Malaysia is ranked today third in terms of healthcare quality, with a very efficient public system, high quality doctors and… ”
“ IMS in Malaysia is possibly the first company to have signed a Memorandum of Understanding with the government for data provision. IMS Health’s general manager introduces… ”
“ Aspen Malaysia’s country manager details the company’s success in the country with a specific business model based on acquiring and remarketing originators. Although Aspen is a renowned… ”
“ The general manager of Sandoz South Latam weighs up the factors that have allowed his company to be the leader in biosimilars and differentiated generics. ”
“ The vice president of Laboratorios Beta discusses the factors of why his organization is ”
“ MGCC’s Executive Director discusses the opportunities and challenges for German pharma and healthcare companies to invest in Malaysia, at a time where most have decided to… ”
“ Clinical Research Malaysia’s CEO discusses the need for Malaysia to focus on high quality pivotal trials rather than simply on a high number of trials. He… ”
“ 2014 marks the 80th anniversary of Laboratorios Bagó, a company founded by your grandfather and developed by your father and uncle. The company is a market… ”
“ The National Heart Institute’s CEO portrays IJN as a national referral center for cardiovascular disease and declares: “IJN is equipped with the best in class technologies… ”
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here